Orgenesis Inc (ORGS) Return on Equity ROE from the fourth quarter 2024 to fourth quarter 2023 and annually, average high and low, overall ranking from Dec 31 2024 to Dec 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Orgenesis Inc   (ORGS)

Orgenesis Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Orgenesis Inc in the fourth quarter 2024?
Due to the lack of equity, it was not possible to calculate Orgenesis Inc 's return on equity (ROE) in its fourth quarter 2024

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change 207.66 % - - - 420.68 %
Net Income (TTM) in Millions 49 35 22 -13 -42
Return On Equity (TTM) - - - - -
ORGS's Total Ranking # # # # #
Equity (TTM) in Millions -38 -24 -16 -28 -21
Seq. Equity Change - - - - -
Seq. Net Income Change 119.9 % -1.07 % -6.39 % 51.06 % -

Back to ORGS Management Effectiveness >> ORGS's 5 Years Annual ROE >> Compare ORGS ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





ORGS Annual Return On Equity (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Equity in Millions -38 -21 29 39 53
Y / Y Equity Change - - -24.75 % -26.74 % 767.52 %
Net Income in Millions 49 65 12 18 1
Y / Y Net Income Change -24.5 % 433.47 % -32.62 % 3019 % -97.78 %
Return On Equity - - 41.86 % 46.75 % 1.1 %

Back to ORGS Management Effectiveness >> ORGS's 5 Years Annual ROE >> Compare ORGS ROE to its Competitors




Annual Roe Comment
Despite deterioration in net income, company improved ROE to in 2024, company improved ROE to 1.1 % compared to the prior year.


More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ORGS's' Return on Equity at Yahoo Finance
ORGS's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ORGS's Competitors
Subscribers only: Roe for Orgenesis Inc 's Suppliers
Subscribers only: Return On Equity for ORGS's Customers




Companies with similar Return On Equity at Dec 31 2024, within Healthcare Sector ROE

Date modified: 2026-06-22T14:32:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.